Aspirin for the prevention of migraine in pregnancy: a retrospective, descriptive case series from a tertiary centre.

This study looked at how low-dose aspirin might help prevent migraines in pregnant women. Researchers reviewed medical records from a London clinic between January 2020 and August 2023. They focused on 73 pregnant women diagnosed with migraines. The study aimed to see how often aspirin was used and whether it improved migraine symptoms. Patients received regular care from their doctors without any special treatments for the study. The researchers noted how many women took aspirin and how their migraine symptoms changed after starting the medication. While the study did not compare aspirin with other treatments, it provided insights into aspirin's role in managing migraines during pregnancy. The findings could help doctors better understand how to treat migraines for pregnant women, especially considering the safety of medications during this time. Clinical relevance: This research highlights the potential benefits of low-dose aspirin for managing migraines in pregnant women, suggesting a safer treatment option during pregnancy.